Cargando…

2263. Fosfomycin Trometerol Use for Complicated UTIs Including Pyelonephritis, a 1-year Review of Outcomes and Prescribing Habits

BACKGROUND: Treatment of complicated urinary tract infections (UTI) caused by multidrug-resistant organisms (MDROs) is increasingly problematic given limited oral antibiotic options. In these situations, fosfomycin is increasingly used. However, there are limited outcome and pharmacokinetic data to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatlen, Timothy J, Flor, Richard, Nguyen, Megan, Miller, Loren G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809988/ http://dx.doi.org/10.1093/ofid/ofz360.1941

Ejemplares similares

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
por: Sharma, Shraddha, et al.
Publicado: (2021)

Is fosfomycin as effective as claimed on MDR Gram-negative bacteria causing UTI? [Letter]
por: Singh, Geeta, et al.
Publicado: (2019)

“Is Fosfomycin As Effective As Claimed On MDR Gram-Negative Bacteria Causing UTI?” [Response To Letter]
por: Gopichand, Pallam, et al.
Publicado: (2019)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

720. Efficacy of Fosfomycin for Injection (FOS) vs. Piperacillin–Tazobactam (PIP-TAZ) in Adults with Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): ZEUS Study Outcomes in Patients With Reduced Study Drug Susceptibility
por: Kaye, Keith S, et al.
Publicado: (2019)

124. Microbiological Outcomes With Plazomicin (PLZ) Versus Meropenem (MEM) in Patients With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis (AP) in the EPIC Study
por: Keepers, Tiffany R, et al.
Publicado: (2018)

2263. HIV-TB Co-Infection in Arizona From 1993 to 2016
por: Damhorst, Gregory, et al.
Publicado: (2018)

Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial
por: Kaye, Keith S, et al.
Publicado: (2019)

731. CERTAIN-1: A Phase 3 Study of Cefepime-Taniborbactam Efficacy and Safety in the Treatment of Complicated Urinary Tract Infections (cUTI), including Acute Pyelonephritis (AP)
por: McGovern, Paul C, et al.
Publicado: (2022)

1524. Are Providers Shifting from NTF to Fosfomycin for Inpatient UTI? Big Data Reveals Small Shifts
por: Gupta, Kalpana, et al.
Publicado: (2018)

PReS-FINAL-2263: Progressive pseudorheumatoid dysplasia in differential diagnosis of juvenile idiopathic arthritis
por: Vrtíková, E, et al.
Publicado: (2013)

1520. Determining the Management of Children with Acute UTI/Pyelonephritis Who Do Not Fit Current Management Recommendations
por: Scanlan, Barry, et al.
Publicado: (2018)

PB2263: TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED/ REFRACTORY HODGKIN LYMPHOMA.
por: Zahra, Kmira, et al.
Publicado: (2023)

1477. A Randomized Phase 2 Study of Cefepime Combined with the Novel Extended Spectrum β-Lactamase Inhibitor Enmetazobactam in Hospitalized Adults with Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP)
por: Carmeli, Yehuda, et al.
Publicado: (2019)

UTI assessment tool for intermittent catheter users: a way to include user perspectives and enhance quality of UTI management
por: Lauridsen, S. V., et al.
Publicado: (2022)

2263 Creating a reference analytics morphomics population from surgical patient cross-sectional imaging
por: He, Katherine, et al.
Publicado: (2018)

PB2263: SUPPORTIVE CARE IN LOW-RISK MYELODYSPLASTIC SYNDROMES: ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS)
por: Cerchione, C., et al.
Publicado: (2022)

1114. Oral β-lactams for the Treatment of Escherichia coli Bacteremia Secondary to Complicated Urinary Tract Infections Including Pyelonephritis
por: Harrington, Nicole, et al.
Publicado: (2019)

Stenotrophomonas maltophilia: Complicating treatment of ESBL UTI
por: Kumar, Simit, et al.
Publicado: (2015)

Acute pyelonephritis including an overlooked renal cell carcinoma
por: Song, Soo Kyeong, et al.
Publicado: (2013)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial
por: Dunne, Michael W, et al.
Publicado: (2022)

Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis
por: Sagan, Olexiy, et al.
Publicado: (2020)

Antibiotic Prescribing in Primary Care for Urinary Tract Infections (UTIs) in Pregnancy: An Audit Study
por: Ghouri, Flavia, et al.
Publicado: (2020)

140. Impact of Pharmacist-led Audit & Feedback on Outpatient Antibiotic Prescribing for UTIs and SSTIs
por: Choi, Patricia, et al.
Publicado: (2020)

Studies on Virulence and Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Isolates and Therapeutic Effect of Fosfomycin in Acute Pyelonephritis Mice
por: Zhang, Lingchun, et al.
Publicado: (2022)

Multicystic dysplastic kidney complicated by pyelonephritis
por: Cooper, Chad J., et al.
Publicado: (2013)

Is it Possible to Change Prescribing Habits?
Publicado: (2005)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Fosfomycin and breastfeeding
Publicado: (2020)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
por: Zhanel, George G., et al.
Publicado: (2020)

2826. Epidemiology of Extended Spectrum Beta-lactamase (ESBL)-producing Enterobacterales and Antimicrobial Resistance in Urinary Tract Infection (UTI) and Acute Pyelonephritis (AP)
por: Fernandez, Maria, et al.
Publicado: (2023)

Susceptibility reporting and antibiotic prescribing for UTIs in the inpatient setting: A nudge toward improved stewardship
por: Ponder, Madison, et al.
Publicado: (2022)

Multiple gas emboli complicating an emphysematous pyelonephritis
por: Razazi, Keyvan, et al.
Publicado: (2018)

A Rare Case of Complicated Emphysematous Pyelonephritis
por: Ojeniyi, Solabomi O, et al.
Publicado: (2023)

Ureteroinguinal herniation complicated by obstructive uropathy and pyelonephritis
por: O'Herlihy, Fergus, et al.
Publicado: (2023)

2263: The effect of family history, alcohol expectancies, and sex differences on hangover symptoms following intravenous alcohol self-administration in nondependent drinkers
por: Daniel Ester, Corbin, et al.
Publicado: (2018)

2263. Amoxicillin Use for Common Acute Respiratory Infections During a National Shortage: Results from the SHARPS-OP Benchmarking Collaborative
por: Lee, Brian R, et al.
Publicado: (2023)

LB-3. Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study
por: Muir, Lori A, et al.
Publicado: (2020)

65. Impact of a Multifaceted Stewardship Intervention on Oral Fosfomycin Prescribing for Treatment of Resistant Organisms in Cystitis
por: Pry, Marie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9ga65qdrv2r6qlu282st6l7dtv